Stryker's 1st-quarter profits surge 220% on a strong comparison with Q1 2014, when recall expenses took $344 million from the bottom line.
Stryker (NYSE:SYK) yesterday topped Wall Street's earning forecast with its 1st-quarter results, buoyed by a strong comparison with Q1 2014.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Gi4pmh
Cap comentari:
Publica un comentari a l'entrada